Medtronic Anticipates Turnaround For Challenged Business Units
This article was originally published in The Gray Sheet
Executive Summary
Executives focused on new developments in the company’s ICD, spine, neuromodulation, and diabetes product lines, which have each faced particular challenges over the past year, during Medtronic’s second-quarter fiscal 2014 earnings call.